The FDA is conducting market research to identify potential sources for a Global Abbreviated New Drug Application (ANDA) Training Program contract. This is a Sources Sought Notice for planning purposes only and does not commit the government to a future solicitation or award. The anticipated period of performance is from September 15, 2026, through September 14, 2031, including a base year and four option years. No specific budget amount is mentioned in the notice. The location for performance of services is not specified.